Patents by Inventor Delia R. Bethell

Delia R. Bethell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS CONTAINING LACTOFERRIN, AND METHODS OF USING SAME TO PROMOTE GROWTH OF SKIN CELLS
    Publication number: 20100329995
    Abstract: The present invention relates, generally, to compositions including lactoferrin, and to compositions including both lactoferrin and lysozyme. The present invention also includes topical formulations containing the compositions, methods of making the formulations, methods of using the formulations to treat various skin disorders/conditions, to treat wounds, and to methods of producing artificial skin using the composition, and methods of treating burns using the formulation, optionally in conjunction with the application of artificial skin.
    Type: Application
    Filed: February 21, 2007
    Publication date: December 30, 2010
    Applicant: VENTRIA BIOSCIENCE
    Inventors: Scott E. Deeter, Delia R. Bethell, Brandy Sargent
  • COMPONENTS OF CELL CULTURE MEDIA PRODUCED FROM PLANT CELLS
    Publication number: 20100015713
    Abstract: The present invention comprises the production of components of cell culture media produced from plant cells and cell culture media containing the same. Heterologous DNA comprising genes encoding the desired component are introduced into plant cells, especially rice, which then produce the desired component. The component can be isolated from the plant cell and combined with other components to form the required cell culture medium.
    Type: Application
    Filed: June 27, 2006
    Publication date: January 21, 2010
    Inventors: Scott Deeter, Joseph E. Schmidt, Kenneth J. Mabery, Delia R. Bethell, Ning Huang, Steve Clyde Pettit
  • Method of making an anti-infective composition for treating oral infections
    Patent number: 7138150
    Abstract: This invention concerns a method of making an anti-infective composition for oral administration using an agent selected from the group consisting of lactoferrin protein and lysozyme protein. The method comprises three steps. The nucleic acid, which encodes a lactoferrin or lysozyme protein, is expressed in a monocot seed. The protein is isolated from the seed. This protein isolation compromises greater than 3% of the total soluble protein in the monocot seed. The protein is then formulated for oral administration.
    Type: Grant
    Filed: August 13, 2003
    Date of Patent: November 21, 2006
    Assignee: Ventria Bioscience
    Inventors: Ning Huang, Jianmin Huang, Delia R. Bethell
  • Method of making an anti-infective composition for treating oral infections
    Publication number: 20040063617
    Abstract: This invention concerns a method of making an anti-infective composition for oral administration using an agent selected from the group consisting of lactoferrin protein and lysozyme protein. The method comprises three steps. The nucleic acid, which encodes a lactoferrin or lysozyme protein, is expressed in a monocot seed. The protein is isolated from the seed. This protein isolation compromises greater than 3% of the total soluble protein in the monocot seed. The protein is then formulated for oral administration.
    Type: Application
    Filed: August 13, 2003
    Publication date: April 1, 2004
    Inventors: Ning Huang, Jianmin Huang, Delia R. Bethell
  • Assay for Non-A Non-B hepatitis
    Patent number: 5635346
    Abstract: New assays for diagnosing NANBH utilizing novel peptide fragments derived from polypeptide antigens reactive to antibodies present in the sera of infected patients are disclosed. In producing these peptides, the portion of the polypeptide contributing to high backgrounds is deleted thereby resulting in assays with an exceptionally high signal to background ratio.
    Type: Grant
    Filed: January 17, 1995
    Date of Patent: June 3, 1997
    Assignee: Dade International Inc.
    Inventors: David C. Leahy, John A. Todd, Michael E. Jolley, Dinesh O. Shah, Delia R. Bethell, Terukatsu Arima